abstract |
Disclosed in the present invention are an anti-TSPAN8 monoclonal antibody and a use thereof, the antibody being able to inhibit proliferation and migration of breast cancer cell lines, and being able to inhibit tumor growth. The antibody can be used to treat and/or prevent diseases mediated by TSPAN8. |